Tezosentan in Pulmonary Arterial Hypertension

Update Il y a 4 ans
Reference: NCT01077297

Woman and Man

Extract

Multicenter, Open-label, Non-comparative, Proof-of-concept, Phase 2a Study to Evaluate the Effect of a Single Infusion of Tezosentan on Pulmonary Vascular Resistance in Patients With Stable, Chronic Pulmonary Arterial Hypertension, Currently Not Treated With Endothelin Receptor Antagonists, Phosphodiesterase-5 Inhibitors or Prostacyclines


Inclusion criteria

  • pulmonary arterial hypertension

Links